Truvada, HIV prevention pill approved by US approves

// Health | Truvada, HIV prevention pill approved by US approves
Email to a friend Plain text Print version // Font size: Decrease font Enlarge font
Truvada

The first-ever daily pill to help prevent against HIV was approved Monday by US regulators for use in uninfected adults who are at risk for getting the virus that causes AIDS.

Truvada, made by Gilead Sciences in California, has been on the market since 2004 and was approved by the Food and Drug Administration for a new use as a tool to help ward off HIV in otherwise healthy people, in combination with safe sex and regular testing.

The pill as pre-exposure prophylaxis (PrEP) has been hailed by some AIDS experts as a potent new tool against human immunodeficiency virus, but some health care providers are concerned it could encourage risky sex behavior.

In addition, the regimen is estimated to cost around $14,000 per year, making it out of reach of many.

“Truvada alone should not be used to prevent HIV infection,” said Debra Birnkrant, director of the division of antiviral products at the FDA.

“Truvada as PrEP represents another effective, evidence-based approach that can be added to other prevention methods to help reduce the spread of HIV.”

The FDA said Truvada should be used as “part of a comprehensive HIV prevention strategy that includes other prevention methods, such as safe sex practices, risk reduction counseling, and regular HIV testing.”

Truvada was previously approved as a treatment for people infected with HIV to be used in combination with other antiretroviral drugs.

The decision by the FDA followed the advice of an independent panel in May that supported Truvada for prevention in uninfected people, after clinical trials showed it could lower the risk of HIV in gay men and heterosexual couples.

One study on Truvada, called the iPrEx trial, published in 2010 in the New England Journal of Medicine included 2,499 men who were sexually active with other men but were not infected with the virus that causes AIDS.

Participants were selected at random to take a daily dose of Truvada — a combination of 200 milligrams of emtricitabine and 300 milligrams of tenofovir disoproxil fumarate — or a placebo.

Those in the study who took the drug regularly had almost 73 percent fewer infections. Across the entire study, including those who had not been as diligent in taking Truvada, there were 44 percent fewer infections than in those who took a placebo.

A second study on 4,758 heterosexual couples in which one partner was infected with HIV and the other was not, showed that Truvada reduced the risk of becoming infected by 75 percent compared with a placebo.

Experts have described the results as game-changing and the first demonstration that an already-approved oral drug could decrease the likelihood of HIV infections.

Common side effects were the same as experienced by people with HIV who were taking Truvada, and included diarrhea, nausea, abdominal pain, headache, and weight loss.

However, adherence rates — meaning how often people in the study actually took the drug daily — were low in the study of men who have sex with men, just 30 percent, Birnkrant said.

In the study of heterosexual partners, adherence was much higher, between 80 and 90 percent.

Therefore, the drug label must include special instructions for health care providers on how to counsel potential users of the drug.

The drugmaker must also include a warning that Truvada for PrEP “must only be used by individuals who are confirmed to be HIV-negative prior to prescribing the drug and at least every three months during use.”

Gilead Sciences is also required to collect samples from people who test positive for HIV while taking the drug and analyze them for signs of drug resistance.

As to concerns about whether the pill might boost risky sex practices and lead people to abandon condoms as a first line of protection, Birnkrant said the studies have not shown that so far.

“We don’t really have any strong evidence to show that condoms were not used or that there was a decrease in condom use when Truvada was used,” she told reporters.

The goal of the approval is to eventually cut back on the rate of new infections in the United States, which have stayed steady in recent years at about 50,000 annually, she said.

A key goal of the US strategy against HIV/AIDS, set forth in 2010, is to decrease the number of new infections by 25 percent by 2015.

“The hope is that over time it will decrease the rate of new infections or incidence in the United States.”

Tagged : AIDS, Truvada, HIV prevention pill

Headlines Newsview all

I Nearly Died With Clem Onyeka - Nzube Onyia

Actress, Nzube Onyia, is one hell of a lucky gal! She was riding with late actor, Clem Onyeka, that fateful day last year in Asaba, ... Full story

Murdered Akwa Ibom Politician’s Son Granted Bail

The Akwa Ibom High Court in Abak on Wednesday granted bail to Odudu Ukpanah, the son of a leader of the Peoples Democratic Party in ... Full story

List Of Men Yvonne Nelson Has Dated

Ghanaian Star Actress Yvonne Nelson started her movie career way back and she actually became one of the hottest and Most Wanted Actress in the ... Full story

Huge Debts Await Buhari's Administration - Debt Management Office

AFTER the euphoria of their electoral victories, one of the major challenges that will confront the President-elect, Major-General Muhammadu Buhari (retd), and 20 or 21 ... Full story

Pastor Adeboye Meets, Prays For David Cameron In London

The General Overseer of the Redeemed Christian Church of God, (RCCG) Pastor E.A Adeboye, prayed for UK Prime Minister, David Cameron and the congregation at ...

Xenophobic violence in South Africa leaves at least five dead, many injured

Anti-immigrant protests have been ongoing in South Africa for two weeks and at least five people have been killed Foreign nationals have been loading trucks with ... Full story

Buruj Kashamu: I Have Never Set Foot Nor Lived In The US (FULL STORY)

Prince Buruji Kashamu, Senator-elect, Ogun East Senatorial District, has responded to an article published in Associated Press. In the report, it was written that Kashamu, who ... Full story

TB Joshua Claims He Predicted South Africa's Xenophobic Attacks

A video has surfaced of Nigerian Prophet Temitope Babatunde Joshua warning South Africans in July 2013 of a ‘youth revolt’ in their nation which would ... Full story

Psquare Brothers Crisis: Peter Goes Solo

There seem to be more trouble and break up looming in Psquare Villa. Barely two days after a new round of family squabbles between PSquare duo ... Full story

Man Indicted In US For Drug Trafficking Elected Senator In Nigeria

A man indicted in America for allegedly smuggling heroin, in a court case that was the basis for the TV hit “Orange Is The New ... Full story

Goodluck Jonathan's Allies Planned To Abduct INEC Chairman To Disrupt Elections

As Muhammadu Buhari closed in on Nigeria's presidency, an aide to election commission chairman Attahiru Jega sent a text message to an independent voting monitor, ... Full story

Comment on: Truvada, HIV prevention pill approved by US approves

Rate this article

0

Featured author

chuky01

Breaking News

Stephen Keshi Apologizes To Nigerians

Stephen Keshi has apologised to Nigerians over his protracted contract talks with the country’s football federation. A very sober coach Keshi in an exclusive interview with ... Full story

Nadia Buari Playing With One Of Her Twin Girls

Nadia Buari is still pulling a Beyonce on us. She shares photos but ensures the faces of her babies are well hidden. See another pic below   ... Full story

Toyin Aimakhu Looks Sassy On Blonde

Becoming more popular for her recent controversial comments and actions, Nollywood actress, Toyin Aimakhu, has decided to make a switch. The talented actress who was recently ...

IK Ogbonna's Girlfriend Rocks Her 8-Months Baby Bump (Photos)

Nollywood actor cum model, Ik Ogbonna should have begun a count down as his girlfriend, Sonia, is close to the final lapse of her Pregnancy. The ...

Rita Dominic, Mildred Okwo, Embark On 'Surulere' Journey

After the huge success of their first feature movie, 'The meeting', the executive Producers Rita Dominic and Mildred Okwo under The Audrey Silva Company have ...

Two Weeks After Birth, Adaeze Yobo Steps Out On A Dinner Date

Out of excitement for hitting the 'big 25', Adaeze Yobo stepped out with hubby, Joseph Yobo, just two weeks after giving birth. Adaeze welcomed her second ...

Jonathan rejects foreign troops in fight against Boko Haram

President Goodluck Jonathan Thursday in Abuja urged the United Nations to focus more on helping Nigeria with the rehabilitation and reconstruction of persons and communities ...

Media Personality, Sarah Ofili, Hits Back At Blogger

On-air personality and model, Sarah Ofili has hit back at some online media for trying drag her name through the mud by saying she called ...

Lil Kesh Celebrate 'Boo' On Her Birthday

Yahoo Boy No Laptop (YBNL) artiste, Lil Kesh, is celebrating the woman who brought him to life today, his mother. The young rapper who dropped the ...

Davido & His Driver Beat Up MC Galaxy To Pulp At Shizzi’s Studio

Davido and MC Galaxy Looks like MC Galaxy and Davido aren’t cool anymore as they used to be after an indicent happened at Shizzi’s studio. Below ...